182
Participants
Start Date
December 16, 2020
Primary Completion Date
July 19, 2023
Study Completion Date
August 31, 2027
Crinecerfont
CRF type 1 receptor antagonist
Placebo
Non-active dosage form
Neurocrine Clinical Site, Brussels
Neurocrine Clinical Site, Vienna
Neurocrine Clinical Site, Sofia
Neurocrine Clinical Site, Sofia
Neurocrine Clinical Site, Leiden
Neurocrine Clinical Site, Leuven
Neurocrine Clinical Site, Graz
Neurocrine Clinical Site, New York
Neurocrine Clinical Site, Belgrade
Neurocrine Clinical Site, Great Neck
Neurocrine Clinical Site, Athens
Neurocrine Clinical Site, Pittsburgh
Neurocrine Clinical Site, Stockholm
Neurocrine Clinical Site, Philadelphia
Neurocrine Clinical Site, Milan
Neurocrine Clinical Site, Milan
Neurocrine Clinical Site, Bethesda
Neurocrine Clinical Site, Winston-Salem
Neurocrine Clinical Site, Madrid
Neurocrine Clinical Site, Atlanta
Neurocrine Clinical Site, Padua
Neurocrine Clinical Site, Grenoble
Neurocrine Clinical Site, Bologna
Neurocrine Clinical Site, Seville
Neurocrine Clinical Site, Gothenburg
Neurocrine Clinical Site, Nantes
Neurocrine Clinical Site, Essen
Neurocrine Clinical Site, Indianapolis
Neurocrine Clinical Site, Ann Arbor
Neurocrine Clinical Site, Angers
Neurocrine Clinical Site, Hradec Králové
Neurocrine Clinical Site, Florence
Neurocrine Clinical Site, Thessaloniki
Neurocrine Clinical Site, Minneapolis
Neurocrine Clinical Site, Rochester
Neurocrine Clinical Site, Ancona
Neurocrine Clinical Site, Frankfurt
Neurocrine Clinical Site, St Louis
Neurocrine Clinical Site, Tel Aviv
Neurocrine Clinical Site, Tulsa
Neurocrine Clinical Site, Dallas
Neurocrine Clinical Site, Paris
Neurocrine Clinical Site, Paris
Neurocrine Clinical Site, Aurora
Neurocrine Clinical Site, Naples
Neurocrine Clinical Site, Munich
Neurocrine Clinical Site, Los Angeles
Neurocrine Clinical Site, San Diego
Neurocrine Clinical Site, San Francisco
Neurocrine Clinical Site, Le Kremlin-Bicêtre
Neurocrine Clinical Site, Seattle
Neurocrine Clinical Site, Messina
Neurocrine Clinical Site, Afula
Neurocrine Clinical Site, Petah Tikva
Neurocrine Clinical Site, Beersheba
Neurocrine Clinical Site, Boston
Neurocrine Clinical Site, Halifax
Neurocrine Clinical Site, Dresden
Neurocrine Clinical Site, Leipzig
Neurocrine Clinical Site, Athens
Neurocrine Clinical Site, Athens
Neurocrine Clinical Site, Roma
Neurocrine Clinical Site, Krakow
Neurocrine Clinical Site, Poznan
Neurocrine Clinical Site, Warsaw
Neurocrine Clinical Site, Porto
Neurocrine Clinical Site, Cardiff
Neurocrine Clinical Site, London
Neurocrine Clinical Site, Manchester
Neurocrine Clinical Site, Salford
Lead Sponsor
Neurocrine Biosciences
INDUSTRY